Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B.
about
HIV-1 drug resistance and resistance testing.HIV-1 genetic variation and drug resistance development.X4 viruses are frequently archived in patients with long-term HIV infection but do not seem to influence the "inflamm-aging" process.Sex differences in HIV outcomes in the highly active antiretroviral therapy era: a systematic reviewDo HIV-1 non-B subtypes differentially impact resistance mutations and clinical disease progression in treated populations? Evidence from a systematic review.Virological failure in patients with HIV-1 subtype C receiving antiretroviral therapy: an analysis of a prospective national cohort in SwedenDisentangling human tolerance and resistance against HIV.HIV-1 antiretroviral resistance: scientific principles and clinical applicationsLong-term virological outcome in children on antiretroviral therapy in the UK and Ireland.Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration.Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial.Impact of HIV-1 Subtype on the Time to CD4+ T-Cell Recovery in Combination Antiretroviral Therapy (cART)-Experienced PatientsThe Impact of HIV Genetic Polymorphisms and Subtype Differences on the Occurrence of Resistance to Antiretroviral Drugs.HIV-1 subtype characteristics of infected persons living in southwestern Greece.Increasing HIV subtype diversity and its clinical implications in a sentinel North American populationNo Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom.Are subtype differences important in HIV drug resistance?Differences in implementation of HIV/AIDS clinical research in developed versus developing world: an evidence-based review on protease inhibitor use among women and minorities.Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study.Comparing Abbott m2000 RealTime HIV test and Roche COBAS Ampliprep/COBAS Taqman HIV test, v2.0 in treated HIV-1 B and non-B subjects with low viraemia.Prevalence of drug resistance mutations in HAART patients infected with HIV-1 CRF06_cpx in Estonia.Trends on epidemiological, virological, and clinical features among newly diagnosed HIV-1 persons in Northwest Spain over the last 10 years.Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe.HIV-1 Subtype C, Tenofovir, and the Relationship With Treatment Failure and Drug ResistanceAcute Retroviral Syndrome is Associated with High Viral Burden, CD4 Depletion, and Immune Activation in Systemic and Tissue Compartments.Identification of Novel Subcellular Localization and Trafficking of HIV-1 Nef Variants from Reference Strains G (F1.93.HH8793) and H (BE.93.VI997)
P2860
Q30245693-8BD56195-866B-49A4-B5D1-E72442CA4DCDQ30354857-2D3D0ECC-A4EF-40CE-B8D1-120B4981A7A4Q31117473-EDF3A1C5-3890-4702-8BF7-9AE2C9C50AF8Q33566578-43CFD0E8-D147-471D-9BAD-E5596594913FQ33850909-A5FD97C6-1B10-418A-B6A8-80FC86AF478EQ33856712-E3225400-913F-43FC-99CC-65F5C4835D44Q34195511-E0BA1EE9-F2DB-40C4-BDA9-F38F6375F39DQ34280466-0659EAC2-381E-4FEE-AB2D-D99D6218F3E2Q34410947-11DF2C60-DD9D-43EF-85E7-BE560E47A191Q34923677-626B2307-0401-4508-A144-CA8A9856F72FQ35588149-76E134CD-1F2E-49C5-99BD-F0BDCE250000Q35763306-3423E46F-4424-4640-8293-792B4B30C695Q36077418-C24541F7-ECCA-4AFB-8AFC-60CC13199E73Q36391005-B7F4904F-736F-4685-81A1-F501220C5767Q37037315-34C393E1-96CC-4FB1-8436-39089E603F65Q37365060-0FCD2B11-B4D4-4159-BDD1-6BA2768D5C72Q37633109-3BBC625A-260E-41E5-81AA-E2978411F385Q38069146-33385093-73A9-4422-9DE3-4C986EE82353Q41004108-CEA2E4DB-D29F-4ECF-A1CE-68B64747A80AQ41020143-D084381E-187D-443F-B042-AE66E75683ACQ41042591-6448B8C6-AEAF-40D8-A109-98DADEC986D2Q41207981-9DBC6391-33AF-425D-AF4D-D5E46F91A71AQ41293200-7D751150-4293-4259-8110-ACD7B9BE310FQ42380140-22DDE540-70B1-4F32-890F-4D3449D9F0BEQ46668682-13C05298-8755-42E8-B5F8-0EFF9A544FD0Q58742287-CCDA5A22-AA22-4B9E-A40A-611E735E2E07
P2860
Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Improved virological outcome i ...... ubtypes compared to subtype B.
@en
Improved virological outcome i ...... ubtypes compared to subtype B.
@nl
type
label
Improved virological outcome i ...... ubtypes compared to subtype B.
@en
Improved virological outcome i ...... ubtypes compared to subtype B.
@nl
prefLabel
Improved virological outcome i ...... ubtypes compared to subtype B.
@en
Improved virological outcome i ...... ubtypes compared to subtype B.
@nl
P2093
P50
P356
P1476
Improved virological outcome i ...... ubtypes compared to subtype B.
@en
P2093
Alexandra U Scherrer
Andri Rauch
Bruno Ledergerber
Leonhard Held
Luigia Elzi
Philippe Bürgisser
Pietro L Vernazza
P304
P356
10.1093/CID/CIR669
P407
P50
P577
2011-10-13T00:00:00Z